Walgreens Boots Alliance Inc
WBA
View Detailed Chart
11.980USD
0.000
Close 09/18, 16:00（ET）Quotes delayed by 15 min
10.37BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+Infinity%
1 Month
-0.17%
6 Months
+7.25%
Year to Date
+28.40%
1 Year
+32.96%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-08-28Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
10.600
Target Price
-11.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 147.66B.
Fairly Valued
The company’s latest is 0.00, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 677.49M shares, decreasing 12.19% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 82.95M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.19.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Ticker SymbolWBA
CompanyWalgreens Boots Alliance Inc
CEOMr. Timothy Charles (Tim) Wentworth
Websitehttps://www.walgreensbootsalliance.com/
